ASCO 2013 Highlights

Expert Opinion published on August 5, 2013 in ASCO 2013 Highlights
Dr. Beer discusses mCRPC including the AFFINITY trial, AA plus prednisone and ipilimumab from the 2013 ASCO annual meeting.
Expert Opinion published on August 5, 2013 in ASCO 2013 Highlights
Dr. Petrylak discusses trials in mCRPC: PSMA ADC; model for predicting OS; second-line therapy aflibercept vs placebo with dtx/predfrom the 2013 ASCO annual meeting.
Expert Opinion published on August 5, 2013 in ASCO 2013 Highlights
Dr. Sartor discusses outcomes from ALSYMPCA and analysis of dtx on sipuleucel-T in PROCEED patients from the 2013 ASCO annual meeting.